The gestalt among frontline physicians is that the hydroxychloroquine/Zithromax treatment with the observed clinical benefit and decline in C Reactive Protein is most likely to be seen if the treatment is begun with the earliest onset of symptoms of fever and dry cough. If it is delayed until shortness of breath, actual pneumonitis or a COVID-19 confirmatory test is in hand, it is less likely to be effective. Try to post accurate information. If a patient requires hospitalization, the death rate regardless of therapy is quite high, probably close to 70% in intubated patients.
As I said I am speaking to hospitalized patients onku. Try to lost accurate information the death rate on hospitalized patients is nowhere near 70% and is likely not that high even in intubated patients